Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2025 · 10-Q
Revenue$25.80M$25.80M+28.0% vs Q2 2024 Net Income-$2.01M-$2.01MN/M vs Q2 2024 EPS Diluted-$0.23-$0.23N/M vs Q2 2024 Gross Profit$23,866,970+31.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,664,011N/M Free Cash Flowderived$902,652N/M Margins · derivedGross margin92.5%+2.5 pt vs Q2 2024
Operating margin9.6%+23.9 pt vs Q2 2024
Net margin-7.8%+9.6 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end